Abstracts Only
SSAT residents Corner
Find SSAT on Facebook SSAT YouTube Channel Follow SSAT on Twitter
Back to 2006 Program and Abstracts
Patterns of Local Failure and Survival for Non-operative Treatment of Stage c0 Distal Rectal Cancer Following Neoadjuvant Chemoradiation Therapy
Angelita Habr-Gama1, Rodrigo O. Perez1, Afonso H. Sousa1, Fabio G. Campos1, Igor E. Proscurshim1, Wladimir Nadalin2, Desiderio R. Kiss1, Joaquim Gama-Rodrigues1; 1Gastroenterology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil; 2Radiology, Univeristy of Sao Paulo School of Medicine, Sao Paulo, Brazil

Background: Neoadjuvant chemoradiation therapy (CRT) is considered the preferred treatment option for distal rectal cancer. Complete pathological response after CRT has led to the proposal for the non-operative as an alternative treatment for highly selected patients with complete clinical response. However, the risk of tumor recurrence and local failure following this strategy remains undetermined. Patients and Methods: 361 patients with distal rectal cancer were managed by neoadjuvant CRT including 5FU, Leucovorin and 5040 cGy. Tumor response assessment was performed at 8 weeks following CRT. Patients with complete clinical response were not immediately operated on and were closely followed. Patients with sustained complete clinical response at 12 months of follow-up were considered clinical stage 0. Patients with incomplete clinical response detected before 12 months of follow-up were managed by immediate radical surgery. Results: 99 patients were considered stage c0 (27.4%) and were managed by non-operative close follow-up. 262 patients (72.6%) were considered to have incomplete clinical response and were managed by radical surgery. Mean follow-up interval for patients with stage c0 was 60 months (12-172). Overall, there were 12 recurrences (12.1%) being 5 exclusively endorectal recurrences (5.1%), 6 systemic recurrences (6%) and 1 combined endorectal and systemic recurrence (1%). All 5 isolated endorectal recurrences were amenable to salvage treatment. There were 5 deaths associated with disease progression. Overall and Disease Free 5-year cancer-related survival was 94% and 86%. Conclusions: Non-operative treatment for sustained complete clinical response following neoadjuvant CRT is safe and associated with high overall and disease-free survival rates. Moreover, local failure is associated with high rates of possibility of salvage therapy and local disease control.


Back to 2006 Program and Abstracts
Quick Links
About the SSAT
Membership
Pay Membership Dues
Meetings & Education
Awards
Foundation
Publications
Advocacy
Donate Today